Company Active LTD

Company profile

Arctech Innovation Limited

Centre of excellence for entomological research

Arctech Innovation Limited is a UK company with status active founded in 2015 based in London.

CRN
09848787
Founded
2015
Age
10

Overview

Legal name
DIGITAL ODOUR TECHNOLOGIES LIMITED
Region
London
Registered address
THE CUBE LONDONEAST-UK BUSINESS AND TECHNICAL PARK
YEW TREE AVENUE
DAGENHAM
ESSEX
UNITED KINGDOM
RM10 7FN
Insolvency history
No

Latest accounts

Financial period: 1 Apr 2024 to 31 Mar 2025

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
-£946,899
Employees
32

Company events

Reference milestones and recent Companies House filing stream events.

15 events
31 Dec
2026

Accounts due

Accounts Due

Next accounts due date

11 Nov
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

01 Jul
2026

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzUyOTgxNDgzN2FkaXF6a2N4

Published 01 Jul 2026 10:13

28 Oct
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar
2025

Accounts filed

Accounts

Last accounts made up date

12 Nov
2024

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzQ0Mjg0MTYzM2FkaXF6a2N4

Published 12 Nov 2024 05:15

11 Nov
2024

Capital Return Purchase Own Shares

Capital

SH03 | Transaction MzQ0MjQ3MjU2NmFkaXF6a2N4 | Paper/PDF filed

Published 12 Nov 2024 02:54

24 Oct
2024

Accounts With Accounts Type Total Exemption Full

Accounts Analysed

AA | Transaction MzQ0MDgwODY0OWFkaXF6a2N4

Published 24 Oct 2024 08:45

24 Oct
2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQ0MDg1MTQyNGFkaXF6a2N4

Published 24 Oct 2024 02:21

24 Oct
2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQ0MDg0OTg4MGFkaXF6a2N4

Published 24 Oct 2024 02:08

24 Oct
2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQ0MDg0ODcwMWFkaXF6a2N4

Published 24 Oct 2024 01:57

19 Oct
2024

Memorandum Articles

Incorporation

MA | Transaction MzQzOTA2ODQyM2FkaXF6a2N4 | Paper/PDF filed

Published 20 Oct 2024 06:15

19 Oct
2024

Resolution

Resolution

RESOLUTIONS | Transaction WURERzMxNEphZGlxemtjeA | Paper/PDF filed

Published 20 Oct 2024 06:13

18 Oct
2024

Capital Cancellation Shares

Capital

SH06 | Transaction MzQzOTA2ODQyNGFkaXF6a2N4 | Paper/PDF filed

Published 19 Oct 2024 06:33

29 Oct
2015

Incorporated

Inception

Company registered at Companies House

Public funding

5 awards
First funded
2018
Funded years
2018, 2019, 2022, 2023
Age at first award
2 years

Projects

2023 Collaborative R&D Lead participant

A next generation smart insect trap combining novel sensors, targeted attractants and remote AI for enhanced pest detection and alerts

1 Nov 2023 to 30 Apr 2025

Awarded
£274,763
Total cost £392,519

Increasing global temperatures, rising urban populations and international travel/trade have resulted in growing populations of pests and non native pest outbreaks. Bed bugs in particular pose a growing challenge with 80% hotels in the U.S reporting infestations in 2018, costing ~$23K/infestation with growing pesticide resistant strains --fuelling demand ...

2023 Collaborative R&D

Trials of solar-powered, active, spatial mosquito control dispensers to reduce Malaria

1 May 2023 to 31 Oct 2025

Awarded
£451,894
Total cost £645,563

Malaria is the single biggest killer in Africa with 670,000 deaths/year, disproportionately affecting pregnant mothers and <5 year-olds. Over 95% of deaths and 94% of cases occur in Sub-Saharan Africa (SSA). Morbidity from frequent bouts of malaria (12,000 cases annually/100,000 population) reduces school and work attendance, trapping families in poverty ...

2022 Collaborative R&D Lead participant

Development of odour-based non-invasive diagnostics (NID) for infectious diseases to deliver affordable, accurate and accessible diagnosis

1 Mar 2022 to 31 Aug 2023

Awarded
£287,270
Total cost £410,386

There are no changes to the published description, as detailed below: Many infectious diseases cause changes in human body odour, generating a profile that can potentially be used for rapid, low-cost and non-invasive diagnosis. Arctech Innovation is building on early research to create a breakthrough diagnostic platform utilising electronic sensors to acc...

2019 Feasibility Studies Lead participant

VecoB - A novel spatial insect repellent

1 Jun 2019 to 28 Feb 2021

Awarded
£195,897
Total cost £279,853

"More than 50% of the global population are at risk of vector-borne diseases such as malaria, Dengue fever, Yellow fever, Zika and Lyme disease, causing 1 billion cases and 1 million deaths per year. Environmental changes are causing an increase in the range and abundance of disease vectors such as mosquitoes and ticks worldwide. The socio-economic cost o...

2018 Collaborative R&D Lead participant

VECOLure: Novel Aggregation Pheromone Bed Bug Lure

1 Jul 2018 to 31 Jan 2020

Awarded
£220,034
Total cost £314,334

The common bed bug, _Cimex lectularius_, is a small, blood-sucking insect that feeds on humans. Bed bugs can't fly or jump, but they are skilled hitchhikers that spread by hiding in your belongings until you get to your destination. Here, the apple pip-sized pests find a new hiding spot until they get hungry. Their bites cause reactions ranging from minor...

Product types

Collaborative R&D Feasibility Studies